Currently Browsing: News

Read More
News

ACRO hosts Congressional Briefing on clinical research advancements

October 24, 2019

On Wednesday, October 23, 2019, ACRO hosted a Congressional Briefing on Capitol Hill. With the help of the Congressional Research & Development…

Read More
NewsReports

A Consistent Approach to Risk Based Quality Management: Collaboration is Key

October 24, 2019

Developing, executing and overseeing clinical trials is a complex process. Yet it is essential to gain reliable evidence from clinical trials to…

Read More
NewsReports

New ACRO Report Quantifies Benefits of RBM for Quality Reviews

October 17, 2019

A new report based on a survey of ACRO members reveals that Risk-Based Monitoring (RBM) makes clinical trial quality review more efficient…

Read More
News

Advancing the Adoption of Risk-Based Monitoring Strategies in Clinical Trials

August 16, 2019

On July 17, 2019, under cooperative agreement with the FDA, the Duke-Margolis Center for Health Policy (Duke Margolis) held a public workshop. The event, titled Improving the Implementation of Risk-Based Monitoring Approaches of Clinical Investigations, aimed to identify opportunities to improve Risk Based Monitoring (RBM) implementation and solicit stakeholder input on the challenges, barriers, and enablers that impact the successful adoption of RBM.

Read More
NewsPress Releases

ACRO offers unique insights on risk-based monitoring of clinical trials, calls for adoption of RBM as a best practice

May 16, 2019

Following meetings with then-Commissioner Scott Gottlieb and senior leadership from the Center for Drug Evaluation and Research on the role of CROs and technology companies in designing and implementing risk-based monitoring (RBM) of clinical trials, ACRO this week submitted extensive comments on recent FDA Guidance.Increasing the use of innovative RBM technologies helps make clinical trials safer, more efficient and higher quality. ACRO’s comments offer unique insights into the recent expansion of RBM implementation and call for further increasing the use of these oversight technologies.

Read More
NewsPress Releases

ACRO expands membership with addition of three digital technology companies

April 15, 2019

The Association of Clinical Research Organizations (ACRO) is pleased to announce the expansion of its membership to include ERT, Oracle and Veeva. These new ACRO member companies, with their focus on digital technologies that enable global clinical trials, characterize the ongoing innovation and evolution of contemporary clinical research. ACRO now has 12 member companies.

Read More
News

ACRO testifies before IRS and Treasury Department on proposed Base Erosion and Anti-Abuse Tax (BEAT) regulation

March 29, 2019

On Monday, March 25, 2019 ACRO provided testimony at a public hearing held by the Internal Revenue Service (IRS) and Treasury Department…

Read More
News

EU efforts turn towards digital for 2019

February 27, 2019

2018 was a busy and productive year for ACRO’s European Scientific & Regulatory Committee, which meets quarterly in London. While the Committee focused largely on the continuing implementation of the EU Clinical Trial Regulation, there were also opportunities to engage with regulators on other topics ranging from European regulatory strategy to Advanced Therapies to the urgent challenges of Brexit.

Read More
NewsPress Releases

Dr. Cynthia Verst of IQVIA Elected 2019 ACRO Chair

January 30, 2019

Washington DC – The Association of Clinical Research Organizations (ACRO) is pleased to announce that its Board of Directors has elected Dr. Cynthia Verst,…

Clinical Research Roundtable event with Lord O'Shaughnessy, Parliamentary Under-Secretary (Department of Health and Social Care) at Barts Health, London, hosted by IQVIA.
Read More
NewsPress Releases

UK Government focus on strengthening clinical research amidst unique challenges of Brexit

November 28, 2018

The Association of Clinical Research Organizations (ACRO) convenes discussion series that seeks to advance an industry with important health and economic impacts…

Read More
News

ACRO members talk UK competitiveness and enabling post-Brexit success

July 18, 2018

What happens to clinical research when the UK leaves the EU’s common market and regulatory structure? When public perceptions seem locked onto…

Read More
News

Who’s in and who’s out? ACRO talks Inclusion-Exclusion Criteria

May 29, 2018

ACRO joins FDA public meeting to discuss trial risks and rationale, benefits and barriers Clinical trials have an enormous number of inter-related,…

Read More
NewsPress Releases

ACRO Opposes Fatally-Flawed Right-To-Try Legislation

May 18, 2018

In May of 2017 the Board of Directors of the Association of Clinical Research Organizations, which represents the world’s leading clinical research…

Read More
NewsPress Releases

British MP Benn talks Brexit challenges and the future of UK clinical research industry

April 18, 2018

The Association of Clinical Research Organizations (ACRO) highlights contributions to health and economy (Leeds, UK) – Facing unprecedented challenges associated with Brexit,…

NewsPress Releases

John Ratliff of Covance Elected 2018 ACRO Chairman

January 25, 2018

WASHINGTON–(BUSINESS WIRE)–The Association of Clinical Research Organizations (ACRO) is pleased to announce that its Board of Directors has elected John Ratliff, CEO of Covance Drug…

NewsPress Releases

ACRO Urges Modernization of the R&D Tax Credit

November 14, 2017

WASHINGTON – November 14, 2017 – As the Senate begins debate on a tax reform bill, the clinical research industry hopes that…

NewsPress Releases

ACRO Testifies About Clinical Trials In New Jersey

October 23, 2017

Washington, DC – October 24, 2017 – On October 19 ACRO Executive Director Doug Peddicord, Ph.D., testified at a public hearing of…

NewsPress Releases

Majority of Americans Open to Clinical Trial Participation If Recommended by a Doctor, New Study Finds

September 6, 2017

WASHINGTON–(BUSINESS WIRE)–The Association of Clinical Research Organizations (ACRO) applauds Research!America for a recently released survey on the public’s perception of clinical trials….

NewsPress Releases

Right to Try ACRO Policy Statement

May 22, 2017

Over the past few years, legislation that would give terminally ill patients access to unapproved treatments, known as “Right-to-Try,” has gained momentum…

NewsPress Releases

ACRO Strongly Endorses Domestic Research Enhancement Act of 2017

April 4, 2017

Contact: John Lewis 202.464.9340 jlewis@acrohealth.org April 4, 2017 (Washington, DC) – The Domestic Research Enhancement Act of 2017 (H.R. 1234), which modernizes…